Assessing Response to Chemoradiotherapy on 18F-FDG PET Images in Non-Small Cell Lung Cancer using New Approaches of Histogram and Gray Level Co-Occurrence Matrix
Journal Title: International Journal of Cancer and Clinical Research - Year 2017, Vol 4, Issue 2
Abstract
Purpose To investigate inherent information provided by 18F-FDG PET to ameliorate shortcomings of relying on visual inspection or sole SUV measurement in treatment assessing. Patients and methods Twelve patients with newly diagnosed NSCLC and treated with combined Chemoradiotherapy (CRT) were involved in this study. We analyzed the percentage variation of gray value in every gray level or on the whole using histogram analysis algorithm which represents global intensity distribution. We also investigated texture parameters which describe local intensity-spatial distribution and were calculated by Gray Level Co-occurrence Matrix (GLCM). The parameters' variation analysis involved comparison between patient's PET scans of pretreatment and 1 month after treatment completion and correlation between characteristics variation and response degree were analyzed. The texture comparison between the same patient's lesions on one side lung and the corresponding tissue with same size, location on the other side normal lung was involved. Results The uniformity degree of gray level distribution on the whole and the maximum ratio decrease were well associated with tumor shrinkage and response degree. In that case, they were capable to differentiate tumor response to CRT. Texture parameters' variation characterizing local tumor metabolism was able to differentiate the response if these parameters were taken as indices because they showed great correlation with regional response to CRT. Conclusion We demonstrated that histogram and texture analysis methods on baseline 18F-FDG PET scans have showed more robust, discriminative in assessing response to combined CRT and may have a good application prospect in clinical practice.
Assessing Response to Chemoradiotherapy on 18F-FDG PET Images in Non-Small Cell Lung Cancer using New Approaches of Histogram and Gray Level Co-Occurrence Matrix
Purpose To investigate inherent information provided by 18F-FDG PET to ameliorate shortcomings of relying on visual inspection or sole SUV measurement in treatment assessing. Patients and methods Twelve patients with ne...
Ipilimumab Activity in Advanced Uveal Melanoma: A Pooled Analysis
Background Uveal Melanoma is a rare tumour that displays different clinical behavior and molecular features compared with cutaneous melanoma. It is generally resistant to systemic therapy and there is no current standard...
The Role of Notch Signaling in Liver Diseases: Contribution to Development and Cancer
Liver tissue consists of several types of cells such as hepatocytes, endothelial cells, stellate cells, cholangiocytes, and immune cells, all with essential functions. The liver plays an important role in metabolism beca...
Clinical Utility of Serum Human Epidermal Growth Factor Receptor Type 2 Testing as a Marker of Therapeutic Response In Tissue HER2-Positive Breast Cancer Patients
Background Human Epidermal growth factor Receptor type 2 (HER2) is over expressed in 20.0-30.0% of breast cancers and is currently evaluated histopathologically. Immunohistochemistry and fluorescence in situ hybridizatio...
Radiolabeled APIs for the Conduct of Human ADME Studies of Oncology Compounds
Human ADME (Absorption, Distribution, Metabolism, and Excretion) studies of new chemical entities are an important part of the drug development process. These studies are normally performed by using a radioactive tracer...